Caliper Life Sciences (CALP) Posts Q3 Loss of $0.01, Beats by 6c; Guides
More News related to CALP
- Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research
- Caliper Life Sciences (CALP) Posts Q3 Loss of $0.01, Beats by 6c; Guides
- Caliper Life Sciences Reports Third Quarter 2009 Results
- Caliper Awarded New Task Order for EPA ToxCast Program
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
Caliper Life Sciences (NASDAQ: CALP) reports Q3 loss of $0.01, 6 cents better than the analyst estimate of ($0.07). Revenue for the quarter was $32.20 million, which compares to the estimate of $29 million.
Sees FY09 Revs of $127 - $129 million, and Q4 revs of $34.5 - $36.5 million, versus $128.20 million and $38.6 million consensus.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
